1.
Staber P, Brezinschek R, Linkesch W, Sill H, Neumeister P. Durable molecular response to imatinib mesylate following nonmyeloablative allogeneic stem-cell transplantation for persisting myeloid blast crisis in chronic myeloid leukemia. Haematologica 2003; 88(8):ECR29-ECR29.